Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE KHEDIMALLAH : revenue, balance sheet and financial ratios

PHARMACIE KHEDIMALLAH is a French company founded 5 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LES ULIS (91940), this company of category PME shows in 2024 a net income positive of 134 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE KHEDIMALLAH (SIREN 892645615)
Indicator 2024 2023 2022 2021
Revenue N/C N/C N/C N/C
Net income 134 346 € 52 863 € 223 983 € 108 888 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE KHEDIMALLAH generates positive net income of 134 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 109 k€ -> 134 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

134 346 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 130%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

129.764%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

36.173%

Solvency indicators evolution
PHARMACIE KHEDIMALLAH

Sector positioning

Debt ratio
129.76 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average -6 pts over 3 years

In 2024, the debt ratio of PHARMACIE KHEDIMALLAH (129.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
36.17% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE KHEDIMALLAH (36.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of PHARMACIE KHEDIMALLAH in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE KHEDIMALLAH is estimated at 1 875 569 € (range 1 306 116€ - 2 805 959€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1306k€ 1875k€ 2805k€
1 875 569 € Range: 1 306 116€ - 2 805 959€
NAF 5 année 2024

Valuation method used

Net Income Multiple
134 346 € × 14.0x = 1 875 569 €
Range: 1 306 117€ - 2 805 959€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE KHEDIMALLAH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE KHEDIMALLAH

What is the revenue of PHARMACIE KHEDIMALLAH ?

The revenue of PHARMACIE KHEDIMALLAH is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE KHEDIMALLAH profitable?

Yes, PHARMACIE KHEDIMALLAH generated a net profit of 134 k€ in 2024.

Where is the headquarters of PHARMACIE KHEDIMALLAH ?

The headquarters of PHARMACIE KHEDIMALLAH is located in LES ULIS (91940), in the department Essonne.

Where to find the tax return of PHARMACIE KHEDIMALLAH ?

The tax return of PHARMACIE KHEDIMALLAH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE KHEDIMALLAH operate?

PHARMACIE KHEDIMALLAH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.